Research
Print page Print page
Switch language
The Capital Region of Denmark - a part of Copenhagen University Hospital
Published

Effect of combination therapy with a calcium channel blocker and an angiotensin-converting enzyme inhibitor on renal hypertrophy and urinary albumin excretion in diabetic rats

Research output: Contribution to journalJournal articleResearchpeer-review

DOI

  1. Mannan-binding lectin in diabetic kidney disease: the impact of mouse genetics in a type 1 diabetes model

    Research output: Contribution to journalJournal articleResearchpeer-review

  2. Sex differences in the association between level of childhood interleukin-6 and insulin resistance in adolescence

    Research output: Contribution to journalJournal articleResearchpeer-review

  3. Growth hormone (GH) hypersecretion and GH receptor resistance in streptozotocin diabetic mice in response to a GH secretagogue

    Research output: Contribution to journalJournal articleResearchpeer-review

  1. Endokrinologi

    Research output: Chapter in Book/Report/Conference proceedingBook chapterCommunication

  2. Diabetes i familien – familien og diabetes

    Research output: Contribution to journalContribution to newspaper - Comment/debateCommunication

  3. Diabetespatienter er afhængige af et løft af det nære sundhedsvæsen

    Research output: Other contributionNet publication - Internet publicationCommunication

View graph of relations

The objective of this study was to compare the effect of an angiotensin-converting enzyme (ACE) inhibitor and a calcium channel blocker on the development of renal changes in diabetic rats. Diabetes was induced by an intravenous injection of streptozotocin in normotensive Wistar rats. Treatment was commenced immediately in 1 set of rats with 4 treatment arms: nitrendipine (250 mg/kg fodder), enalapril (35 mg/L drinking water), both treatments in combination, or placebo. Treatment was continued for 9 weeks. Another set of rats was left with untreated diabetes for 3 months followed by 7 weeks treatment as above. When starting treatment right after induction of diabetes, nitrendipine significantly reduced urinary albumin excretion (UAE) to the nondiabetic level (P < .05) without reducing blood pressure (BP), whereas enalapril failed to significantly reduce UAE despite a reduction in BP. Combining the two treatments showed no further reduction in UAE compared to monotherapy with nitrendipine, despite a lower BP. When leaving diabetic rats untreated for 3 months, only the coadministration of nitrendipine and enalapril showed a significant reduction in UAE compared to monotherapy and placebo treatment, but showed no significant effect on BP.

Original languageEnglish
JournalExperimental Diabesity Research
Volume4
Issue number3
Pages (from-to)191-9
Number of pages9
ISSN1543-8600
DOIs
Publication statusPublished - 6 Apr 2004
Externally publishedYes

    Research areas

  • Albuminuria, Angiotensin-Converting Enzyme Inhibitors, Animals, Calcium Channel Blockers, Diabetes Mellitus, Type 1, Diabetic Nephropathies, Drug Therapy, Combination, Enalapril, Female, Kidney, Nitrendipine, Rats, Rats, Wistar, Journal Article, Research Support, Non-U.S. Gov't

ID: 51976826